DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted ¹⁷⁷Lu-Radionuclide Tumor Therapy in Mice

Coney, 1991, Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein, Cancer Res., 51, 6125

Weitman, 1992, Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Cancer Res., 52, 3396

Garin-Chesa, 1993, Trophoblast and ovarian cancer antigen LK26: sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein, Am J Pathol., 142, 557

10.1016/j.ab.2004.12.026

10.1021/ar7000815

10.1016/j.cbpa.2009.03.022

10.1007/s10555-008-9155-6

10.2967/jnumed.110.076018

10.2174/138161212799315777

10.1002/jps.20457

10.1007/s10555-007-9048-0

10.1016/j.addr.2004.01.008

10.1021/bc049709b

10.1007/s00280-005-0151-z

10.1158/0008-5472.CAN-06-3894

10.1158/0008-5472.CAN-07-0033

10.1177/0091270009339740

10.1053/j.semnuclmed.2008.05.002

10.1159/000227808

10.1158/1078-0432.CCR-11-0483

10.1016/j.addr.2004.01.004

Holm, 1992, A high-affinity folate binding-protein in proximal tubule cells of human kidney, Kidney Int., 41, 50, 10.1038/ki.1992.7

10.1681/ASN.2004080711

10.1152/ajpcell.00006.2004

10.1074/jbc.M205854200

10.1158/0008-5472.CAN-06-2531

10.1002/anie.200704936

10.1021/bc9002772

10.1016/j.nucmedbio.2010.12.013

10.1002/(SICI)1097-0215(19971210)73:6<859::AID-IJC16>3.0.CO;2-#

Mathias, 1996, Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate, J Nucl Med., 37, 1003

10.1007/s00259-008-1058-9

10.1007/s00259-006-0111-9

10.1016/j.jorganchem.2004.08.045

10.2967/jnumed.107.047704

Müller, 2006, Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo, J Nucl Med., 47, 2057

10.1021/mp900296k

10.1007/s00259-010-1597-8

Reddy, 2004, Preclinical evaluation of 99mTc-EC20 for imaging folate receptor-positive tumors, J Nucl Med., 45, 857

10.2967/jnumed.110.075101